Armata Pharmaceuticals Stock Target Price and Analyst Consensus
| ARMP Stock | USD 2.51 0.16 5.99% |
The current analyst and expert consensus on Armata Pharmaceuticals is Strong Buy, with only one strong buy opinion. The current projected Armata Pharmaceuticals target price consensus is 8.00 with 2 analyst opinions. The most common way Armata Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Armata Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Armata Pharmaceuticals. We encourage you to use your own analysis of Armata Pharmaceuticals to validate this buy or sell advice. Armata Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Armata Pharmaceuticals target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Armata Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Armata Stock, please use our How to Invest in Armata Pharmaceuticals guide.
Lowest Forecast 7.28 | Highest Forecast 8.88 | Target Price 8 |
Armata |
It's important to approach Armata Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Armata Pharmaceuticals price targets
Armata Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Armata Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Armata Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Armata Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Armata Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Armata Pharmaceuticals is a key component of Armata Pharmaceuticals valuation and have some predictive power on the future returns of a Armata Pharmaceuticals.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Armata Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Investor Favorites Invested a lot of shares | |
 | Chemicals Invested over 40 shares | |
 | Baby Boomer Prospects Invested over 50 shares | |
 | Hedge Favorites Invested few shares | |
 | Driverless Cars Invested over 70 shares | |
 | Momentum Invested over 200 shares | |
 | Power Assets Invested over 200 shares | |
 | Dividend Beast Invested over 70 shares | |
Check out Macroaxis Advice on Armata Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Armata Stock, please use our How to Invest in Armata Pharmaceuticals guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Armata Stock analysis
When running Armata Pharmaceuticals' price analysis, check to measure Armata Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Armata Pharmaceuticals is operating at the current time. Most of Armata Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Armata Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Armata Pharmaceuticals' price. Additionally, you may evaluate how the addition of Armata Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
The data published in Armata Pharmaceuticals' official financial statements usually reflect Armata Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Armata Pharmaceuticals. For example, before you start analyzing numbers published by Armata accountants, it's critical to develop an understanding of what Armata Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Armata Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Armata Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Armata Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Armata Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Armata Pharmaceuticals' management manipulating its earnings.